0001779535-21-000001.txt : 20210623
0001779535-21-000001.hdr.sgml : 20210623
20210623171313
ACCESSION NUMBER: 0001779535-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210623
DATE AS OF CHANGE: 20210623
EFFECTIVENESS DATE: 20210623
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lyndra Therapeutics, Inc.
CENTRAL INDEX KEY: 0001679037
IRS NUMBER: 472817157
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-403985
FILM NUMBER: 211039439
BUSINESS ADDRESS:
STREET 1: 65 GROVE STREET, SUITE 301
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 857-267-5746
MAIL ADDRESS:
STREET 1: 65 GROVE STREET, SUITE 301
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: Lyndra, Inc.
DATE OF NAME CHANGE: 20160707
D
1
primary_doc.xml
X0708
D
LIVE
0001679037
Lyndra Therapeutics, Inc.
65 GROVE STREET, SUITE 301
WATERTOWN
MA
MASSACHUSETTS
02472
857-201-5314
DELAWARE
Lyndra, Inc.
Corporation
true
Patricia
Hurter
c/o Lyndra Therapeutics, Inc.
65 Grove Street, Suite 301
Watertown
MA
MASSACHUSETTS
02472
Executive Officer
Director
Zafi
Avnur
c/o Lyndra Therapeutics, Inc.
65 Grove Street, Suite 301
Watertown
MA
MASSACHUSETTS
02472
Director
Robert
Langer
c/o Lyndra Therapeutics, Inc.
65 Grove Street, Suite 301
Watertown
MA
MASSACHUSETTS
02472
Director
Catherine
Reynolds
c/o Lyndra Therapeutics, Inc.
65 Grove Street, Suite 301
Watertown
MA
MASSACHUSETTS
02472
Director
Amy
Schulman
c/o Lyndra Therapeutics, Inc.
65 Grove Street, Suite 301
Watertown
MA
MASSACHUSETTS
02472
Director
Carlo
Giovanni
Traverso
c/o Lyndra Therapeutics, Inc.
65 Grove Street, Suite 301
Watertown
MA
MASSACHUSETTS
02472
Director
Jessica
Ballinger
c/o Lyndra Therapeutics, Inc.
65 Grove Street, Suite 301
Watertown
MA
MASSACHUSETTS
02472
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2021-06-08
false
true
false
0
65000000
60470112
4529888
false
22
0
0
0
false
Lyndra Therapeutics, Inc.
Patricia Hurter
Patricia Hurter
Chief Executive Officer
2021-06-23